Related Content
Search Google Scholar for:
|
|
Science 28 April 1978:
Vol. 200. no. 4340, pp. 456 - 458
DOI: 10.1126/science.644310
|
|
Articles
Science, Vol 200, Issue 4340, 456-458
Copyright © 1978 by American Association for the Advancement of Science
Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain
IJ Farley,
KS Price,
E McCullough,
JH Deck,
W Hordynski,
and
O Hornykiewicz
In postmortem examination of brains of four patients with chronic paranoid schizophrenia, above-normal norepinephrine levels were measured in the ventral septum, the bed nucleus of the stria terminalis, the nucleus accumbens, and the mammillary bodies. No changes were detected in other limbic forebrain regions, including the hypothalamus and the medial olfactory (preoptic) area. The results point to the possibility of a malfunction of limbic noradrenergic mechanisms in schizophrenia, especially the paranoid variety.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Phencyclidine-Induced Deficits in Prepulse Inhibition of Startle are Blocked by Prazosin, an Alpha-1 Noradrenergic Antagonist.
- V. P. Bakshi and M. A. Geyer (1997)
J. Pharmacol. Exp. Ther.
283, 666-674
| Abstract »
| Full Text »
- Abnormal Reinnervation as a Basis for Schizophrenia: A Hypothesis.
- J. R. Stevens (1992)
Arch Gen Psychiatry
49, 238-243
| Abstract »
| PDF »
- Plasma 3-Methoxy-4-Hydroxyphenylglycol Changes Associated With Clinical State and Schizophrenic Subtype.
- G. N. Ko, D. C. Jimerson, R. J. Wyatt, and L. B. Bigelow (1988)
Arch Gen Psychiatry
45, 842-846
| Abstract »
| PDF »
- Effect of Neuroleptics on Altered Cerebral Glucose Metabolism in Schizophrenia.
- H. Szechtman, C. Nahmias, E. S. Garnett, G. Firnau, G. M. Brown, R. D. Kaplan, and J. M. Cleghorn (1988)
Arch Gen Psychiatry
45, 523-532
| Abstract »
| PDF »
- Noradrenergic Function in Schizophrenia.
- W. M. Glazer, D. S. Charney, and G. R. Heninger (1987)
Arch Gen Psychiatry
44, 898-904
| Abstract »
| PDF »
- Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm.
- S Kalsner and R Richards (1984)
Science
223, 1435-1437
| Abstract »
| PDF »
- {alpha}-Adrenergic Receptor Function in Schizophrenia: Receptor Number, Cyclic Adenosine Monophosphate Production, Adenylate Cyclase Activity, and Effect of Drugs.
- M. S. Kafka and D. P. van Kammen (1983)
Arch Gen Psychiatry
40, 264-270
| Abstract »
| PDF »
- Plasma Norepinephrine and Dopamine-{beta}-Hydroxylase Activity in Schizophrenia.
- S. Castellani, M. G. Ziegler, D. P. van Kammen, P. E. Alexander, S. G. Siris, and C. R. Lake (1982)
Arch Gen Psychiatry
39, 1145-1149
| Abstract »
| PDF »
- Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
- D. Sternberg, D. VanKammen, P Lerner, and W. Bunney (1982)
Science
216, 1423-1425
| Abstract »
| PDF »
- Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia: Effects of Clonidine in Schizophrenic Patients and Normal Controls.
- D. E. Sternberg, D. S. Charney, G. R. Heninger, J. F. Leckman, K. M. Hafstad, and D. H. Landis (1982)
Arch Gen Psychiatry
39, 285-289
| Abstract »
| PDF »
- Schizophrenia: elevated cerebrospinal fluid norepinephrine.
- C. Lake, D. Sternberg, D. van Kammen, J. Ballenger, M. Ziegler, R. Post, I. Kopin, and W. Bunney (1980)
Science
207, 331-333
| Abstract »
| PDF »
- Brain norepinephrine and dopamine in schizophrenia.
- E. Bird, E. Spokes, and L. Iversen (1979)
Science
204, 93-94
| PDF »
- Telemetered EEG-EOG During Psychotic Behaviors of Schizophrenia.
- J. R. Stevens, L. Bigelow, D. Denney, J. Lipkin, A. H. Livermore Jr, F. Rauscher, and R. J. Wyatt (1979)
Arch Gen Psychiatry
36, 251-262
| Abstract »
| PDF »
|
|
